84. サルコイドーシス Sarcoidosis Clinical trials / Disease details
臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00279708 (ClinicalTrials.gov) | January 2006 | 18/1/2006 | Atorvastatin to Treat Pulmonary Sarcoidosis | Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial | Sarcoidosis, Pulmonary | Drug: Atorvastatin;Other: Placebo Oral Tablet | National Heart, Lung, and Blood Institute (NHLBI) | NULL | Completed | 18 Years | 70 Years | All | 55 | Phase 2 | United States |